Henao-Guerrero Natalia, Riccó Carolina H
Department of Small Animal Clinical Sciences, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, VA 24061.
Am J Vet Res. 2014 Mar;75(3):231-9. doi: 10.2460/ajvr.75.3.231.
To evaluate the cardiorespiratory effects of IV administration of propofol (4 mg/kg), ketamine hydrochloride and propofol (2 mg/kg each; K-P), or ketamine hydrochloride (5 mg/kg) and diazepam (0.2 mg/kg; K-D) before and after induction of anesthesia (IoA) in dogs sedated with acepromazine maleate and oxymorphone hydrochloride.
10 healthy adult Beagles.
Each dog was randomly allocated to receive 2 of 3 treatments (1-week interval). For instrumentation prior to each treatment, each dog was anesthetized with isoflurane. After full recovery, acepromazine (0.02 mg/kg) and oxymorphone (0.05 mg/kg) were administered IV. Fifteen minutes later (before IoA), each dog received treatment IV with propofol, K-P, or K-D. Cardiorespiratory and arterial blood gas variables were assessed before, immediately after, and 5 minutes after IoA.
Compared with findings before IoA, dogs receiving the K-P or K-D treatment had increased cardiac output, oxygen delivery, and heart rate 5 minutes after IoA; K-P administration did not change mean arterial blood pressure or stroke volume and decreased systemic vascular resistance. Propofol decreased mean arterial blood pressure and systemic vascular resistance immediately after IoA but did not change heart rate, cardiac output, or oxygen delivery. All treatments caused some degree of apnea, hypoventilation, and hypoxemia (Pao2 < 80 mm Hg).
In dogs, K-P treatment maintained mean arterial blood pressure better than propofol alone and increased heart rate, cardiac output, or oxygen delivery, as did the K-D treatment. Supplemental 100% oxygen should be provided during IoA with all 3 treatments.
评估在以马来酸乙酰丙嗪和盐酸羟吗啡酮镇静的犬只中,麻醉诱导(IoA)前后静脉注射丙泊酚(4mg/kg)、盐酸氯胺酮与丙泊酚(各2mg/kg;K-P)或盐酸氯胺酮(5mg/kg)与地西泮(0.2mg/kg;K-D)对心肺的影响。
10只健康成年比格犬。
每只犬随机分配接受3种治疗中的2种(间隔1周)。在每次治疗前进行仪器安装时,每只犬用异氟烷麻醉。完全恢复后,静脉注射乙酰丙嗪(0.02mg/kg)和羟吗啡酮(0.05mg/kg)。15分钟后(IoA前),每只犬静脉接受丙泊酚、K-P或K-D治疗。在IoA前、IoA后即刻和IoA后5分钟评估心肺和动脉血气变量。
与IoA前的结果相比,接受K-P或K-D治疗的犬在IoA后5分钟心输出量、氧输送和心率增加;给予K-P未改变平均动脉血压或每搏输出量,并降低了全身血管阻力。丙泊酚在IoA后即刻降低了平均动脉血压和全身血管阻力,但未改变心率、心输出量或氧输送。所有治疗均引起一定程度的呼吸暂停、通气不足和低氧血症(动脉血氧分压<80mmHg)。
在犬中,K-P治疗比单独使用丙泊酚能更好地维持平均动脉血压,且与K-D治疗一样能增加心率、心输出量或氧输送。在使用所有3种治疗进行IoA期间应提供补充的100%氧气。